The Discounted Cash Flow (DCF) valuation of Mayne Pharma Group Ltd (MYX.AX) is (71.96) AUD. With the latest stock price at 6.48 AUD, the upside of Mayne Pharma Group Ltd based on DCF is -1210.5%.
Based on the latest price of 6.48 AUD and our DCF valuation, Mayne Pharma Group Ltd (MYX.AX) is a sell. selling MYX.AX stocks now will result in a potential gain of 1210.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.4% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (155.94) - (48.12) | (71.96) |
| Upside | -2506.4% - -842.6% | -1210.5% |